Skip to main
TEM
TEM logo

TEM Stock Forecast & Price Target

TEM Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 45%
Buy 18%
Hold 36%
Sell 0%
Strong Sell 0%

Bulls say

Tempus AI Inc reported a significant growth trajectory, with total revenue increasing by 35.9% year-over-year in the third quarter of 2024, primarily propelled by a 30.6% rise in Genomics revenue and a notable 44.6% expansion in its Data & Other segment. The company also demonstrated robust operational performance by delivering 72.5k NGS tests, reflecting an upward trend from both the previous quarter and the same period last year. Furthermore, the guidance suggests that core Tempus can achieve approximately 30% growth, while improvements in EBITDA burn indicate a promising financial outlook for Fiscal Year 2024.

Bears say

Tempus AI is facing significant challenges that could hinder its growth potential and profitability, primarily due to the risk of declining reimbursement rates and the possibility of losing market share in genomic testing. Furthermore, the company operates in a highly competitive environment, which places additional pressure on its ability to retain customers and monetize its expansive dataset. Financially, Tempus has demonstrated stagnant operating cash flow year-over-year, ending the fourth quarter of 2024 with a considerable debt load that raises concerns about its long-term financial stability.

TEM has been analyzed by 11 analysts, with a consensus rating of Buy. 45% of analysts recommend a Strong Buy, 18% recommend Buy, 36% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Tempus AI Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Tempus AI Inc (TEM) Forecast

Analysts have given TEM a Buy based on their latest research and market trends.

According to 11 analysts, TEM has a Buy consensus rating as of Jul 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $65.09, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $65.09, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Tempus AI Inc (TEM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.